Back to search

Belgium· BE-AMP-SAM270751-00

SMOFlipid 200 mg/ml

A fettemulsionen product containing triglycerides medium chain, registered in Belgium by Fresenius Kabi. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedSMOFlipid 200 mg/mlATCB05BA02REGISTER NO.BE-AMP-SAM270751-00PACKS LISTED4CHECKEDSeptember 26, 2026

Where it is registered

Fettemulsionen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA02 (fettemulsionen), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Fettemulsionen · ATC B05BA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Triglycerides Medium Chain
Manufacturer
Fresenius Kabi
Country
Belgium (BE)
ATC code
B05BA02
ATC class
Fettemulsionen
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 4

2 priced
  • be_apb
    0786566
  • be_apb
    2437077
    EUR 17.53
  • be_apb
    0786590
  • be_apb
    2437119
    EUR 17.53

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fettemulsionen in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fettemulsionen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d17b90ce-7b1e-40a8-8e92-141908812bb9
GET /v1/drugs/d17b90ce-7b1e-40a8-8e92-141908812bb9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Emulsion for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "SMOFlipid 200 mg/ml",
  "name_fr": "SMOFlipid 200 mg/ml",
  "name_nl": "SMOFlipid 200 mg/ml",
  "amp_code": "SAM270751-00",
  "strengths": [
    "60.0000",
    "60.0000",
    "60.0000",
    "60.0000",
    "30.0000",
    "30.0000",
    "50.0000",
    "50.0000",
    "25.0000",
    "25.0000",
    "0.3000"
  ],
  "pack_count": 7,
  "substances": [
    "Triglycerides Medium Chain",
    "Glycine max - Glycine soja (Ph.Eur. mixture), Bean, Oil",
    "Fish Oil Rich in Omega-3-Acids",
    "Olea europaea L., Fruit, Oil - Purified",
    "Glycerol",
    "Sodium Hydroxide",
    "Sodium Oleate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Fat Emulsions",
  "authorisation_numbers": [
    "BE270751",
    "BE277487",
    "BE484933"
  ]
}

See everything about fettemulsionen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.